FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/12/098338 [Registered on: 02/12/2025] Trial Registered Prospectively
Last Modified On: 02/12/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Preventive
Process of Care Changes
Behavioral 
Study Design  Single Arm Study 
Public Title of Study   Snakebite Awareness, Response, Prevention and Action (SARPA) 
Scientific Title of Study   Zero snakebite death initiative; community empowerment and engagement for mitigation of snakebite envenoming. SARPA (Snakebite Awareness, Response, Prevention and Action) 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Jaideep C Menon 
Designation  Professor 
Affiliation  Amrita Institute of Medical Sciences, Kochi 
Address  Department of Cardiology, Amrita Institute of Medical Sciences, Ponekkara P.O , kochi, Ernakulam, Kerala

Ernakulam
KERALA
682041
India 
Phone  9895122099  
Fax    
Email  menon7jc@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Jaideep C Menon 
Designation  Professor 
Affiliation  Amrita Institute of Medical Sciences, Kochi 
Address  Department of Cardiology, Amrita Institute of Medical Sciences, Ponekkara P.O , kochi, Ernakulam, Kerala


KERALA
682041
India 
Phone  9895122099  
Fax    
Email  menon7jc@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Jaideep C Menon 
Designation  Professor 
Affiliation  Amrita Institute of Medical Sciences, Kochi 
Address  Department of Cardiology, Amrita Institute of Medical Sciences, Ponekkara P.O , kochi, Ernakulam, Kerala


KERALA
682041
India 
Phone  9895122099  
Fax    
Email  menon7jc@gmail.com  
 
Source of Monetary or Material Support  
Indian Council of Medical Research, Department of Health and Research, V.Ramalingaswami Bhawan, Ansari nagar, Post Box No-4911, New Delhi, India. Pin: 110029 
 
Primary Sponsor  
Name  Indian Council of Medical Research 
Address  V.Ramalingaswami Bhawan, Ansari nagar, Post Box No-4911, New Delhi-110029 
Type of Sponsor  Government funding agency 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 7  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Sunil Kumar Panigrahi  All India Institute of Medical Sciences, Deoghar  Cabin 2- Assistant Professor, Department of Community & Family Medicine, First floor, Academic Billing, AIIMS, Deoghar, Devipur, Jharkhand 814152
Deoghar
JHARKHAND 
8424017937

sunil.cfm@aiimsdeoghar.edu.in 
Jaideep C Menon  Amrita Institute of Medical Sciences, Kochi  Room No.06, 6th floor - Nalanda block (Department of Public Health), Amrita Institute of Medical Sciences, Ponekkara P.O,Kochi, Pin;682041,Kerala.
Ernakulam
KERALA 
9895122099

menon7jc@gmail.com 
Surajit Giri  Demow CHC cum Model Hospital  Room No.02, Operation Theatre Complex, First floor, Department of Anaesthesia,Demow CHC cum Model Hospital, Demow, Sivasagar district, Pin:785662
Sibsagar
ASSAM 
9435056627

drsurajitgiri@gmail.com 
Srikanta Kanungo  ICMR- Regional Medical Research Centre, Bhubaneswar  Room 205, Annex building,ICMR- RMRC, NALCO Nagar, Chandrasekharpur, Bhubaneswar, Odisha 751023
Puri
ORISSA 
8307932643

srikantak109@gmail.com 
Nirmalya Mukherjee  MANT  The Chambers, Space no. 006 & 007, Ground floor, 1865 Rajdanga Main Road Kolkata – 700107, West Bengal, India
South Twentyfour Parganas
WEST BENGAL 
8420011313

nirmalya@cphr-mant.org  
Rahul Gajbhiye  Model Rural Health Research Unit (MRHRU), Vani  Room No.1, MRHRU Vani, Rural Hospital Campus, Kasabe Vani, Taluka Dindori, Dstrict Nasik, Maharashtra, 422215
Nashik
MAHARASHTRA 
9819336343

gajbhiyer@nirrh.res.in 
Omesh Kumar Bharti  State Institute of Health and Family Welfare, Parimahal   Office of State Epidemiologist, Department of Health & Family Welfare, SIHFW Kasumpti Shimla- India-171009.
Kangra
HIMACHAL PRADESH 
9418120302

bhartiomesh@yahoo.com 
 
Details of Ethics Committee  
No of Ethics Committees= 7  
Name of Committee  Approval Status 
Ethics Committe of Amrita School of Medicine  Approved 
Ethics Committe of Amrita School of Medicine  Approved 
Ethics Committe of Amrita School of Medicine  Approved 
Human Research Ethics Committee at MANT  Approved 
ICMR-NIRRCH Ethics Committe for Human Studies  Approved 
IEC OF AIIMS DEOGHAR  Approved 
Institutional Human Ethics Committe, ICMR-RMRC, Bhubaneswar  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Snakebite envenomation 
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Behavioral interventions   Use of a well tucked mosquito net. Use of toilets and avoid open defecation. Situational use of boots and gloves. Use of torchlights or mobiles flashlight at night while walking in the dark. Deploy signages with visual snakebite prevention cues in high-risk zones like agricultural fields, plantations, saw-mills, brick-kilns etc. 
Intervention  Community awareness  Information, education, communication (IEC) material in digital and analogue formats for community awareness on snakes of the region. Audio-visual narrowcasting and community screening of videos in the regional language. IEC material on preventive aspects, integrate behavioural nudges like reminders to use torch, boots, mosquito nets, and culturally adapted storytelling to aid prevention. IEC on ‘dos and don’ts’ if bitten and first-aid measures. Contextual edutainment tools like the gamified version of the ‘Snakes and ladders’ game for schoolchildren. Observing ‘World snake day’ and ‘World snakebite day’ so as to help spread awareness IVRS in the local language to send personalized reminders on preventive aspects on the basis of state and district level assessments. Special sessions targeting women in self-help groups, emphasizing on safe sleeping practices and use of mosquito nets. 
Intervention  Community empowerment  Through empowering 5 members in each panchayat from established work-pools of ASHAs, snake rescuers, Gram Sewak’s, Kudumbasree, Haritha Sena, Disaster network recruits,forest guards or other volunteers. Training identified members 5 for each panchayat on common venomous and non-venomous species, look-alike of the Big 4 species, dos and don’ts, first-aid, identification of sentinel symptoms of envenoming, facilitate transport and alert for transport of envenomed victims. Awareness sessions led by the trained workers on preventive aspects for the community especially for at-risk groups with outdoor occupations and in high-burden areas. 
Intervention  Digital technology   A Digital App which facilitates victim transport. ICE material on prevention and all other aspects with regards to prevention, first-aid, therapy, transport would be available on the App. The App would also be a link to the 24-hour helpline. The App would also serve as a resource on snakes of the region, hospitals in the area treating snakebite and help facilitate transport in an ambulance. The App would help map hot spots from incidents, snake sightings and rescues and the information gathered along with data gathered on the agro-ecological and climate parameters would help developing a score for the risk of snakebite and SBE. 
Intervention  Facilitating treatment of victims  Transport of victims to tertiary centres in ambulance with staff capable of treating with ASV. A ‘hub and spoke’ model of transfer and treatment of victims at three levels L1, L2 and L3 centres, L1 with basic care and lacking an ICU, L2, ICU without ventilatory or dialysis facilities, L3 with advanced support systems including dialysis, ventilation and plasmapheresis. 24-hour snakebite helpline guiding diagnosis and therapy. Drones for transport of ASV in difficult to reach geographies or during natural calamities. Ensuring stocks of ASV in treating centres through a system of radio-tagged vials. 
Comparator Agent  NIL  NIL 
Intervention  Strengthening health systems  Training sessions on basic life support skills for doctors and other paramedical personnel including use of the laryngeal mask, and Ambu bag and mask ventilation. Training sessions for doctors in PHCs and CHCs (six modules – Identification, Preventive aspects, Signs and symptoms, Treatment and complications, Policy, legislation, law, compensation etc. with regards to snakebite and SBE. IEC material and flow-charts on the syndromic approach to treatment, charts depicting the common venomous snakes of the geography in the regional language, flow-chart on treatment guidelines with ASV dosing etc in all the public and private centres of treating snakebite. Training of pharmacists and nurses on nuances of infusing ASV during transit, first aid and basic life-support.  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  The intervention targets all relevant stakeholders across the snakebite care pathway, from prevention and early response to hospital-based treatment and policy integration. Participants are grouped into the following categories:

a. Community Members: Residents of high-burden snakebite areas, particularly those whose occupations increase exposure risk, such as agricultural workers, forest gatherers, and outdoor labourers. These populations are central to both prevention and early detection strategies.

b. Community Volunteers (Sarpa Mitras): Locally identified individuals trained to serve as first responders. Sarpa Mitras will be selected from established networks such as self-help groups (SHGs) and grassroots health workers’ collectives. They will be trained in recognizing venomous species, providing correct first-aid, stabilizing victims, ensuring safe transport, and conducting community awareness sessions.
c. Healthcare Providers: A wide spectrum of providers will be engaged, including medical officers, nurses, pharmacists, ambulance personnel, Accredited Social Health Activists (ASHAs), and Auxiliary Nurse Midwives (ANMs). These individuals will receive refresher training on evidence-based snakebite management and referral protocols.

d. Policy and System-Level Stakeholders: State and district health officials, Panchayat Raj Institutions (PRIs), and NGO representatives will be involved to facilitate system-level integration, policy alignment, and sustainability planning.
For the project, the intervention will be implemented across 14 blocks in 7 states, targeting all key stakeholders along the snakebite care pathway. The study population will include (I) Community members residing in high-risk areas, sampled through household surveys at baseline and endline to capture changes in awareness and practices. Approximately 100 households per block will be surveyed, yielding about 1,400 households in total. (II) Community volunteers (Sarpa Mitras): Five Sarpa Mitras will be identified from each panchayat, with the total number varying depending on the number of panchayats within a block. This approach ensures representation across villages while creating a strong local network of trained volunteers. (III) Healthcare workers: Training will be extended to different cadres of health providers, with approximate targets per block of 15–20 medical officers, 20–25 nurses and pharmacists, 10–15 ambulance personnel, and 20–25 frontline workers (ASHAs, ANMs). The final numbers will vary according to the number of CHCs, PHCs and rural hospitals in each block, but overall coverage across all sites is expected to be comprehensive. (IV) Policy and system-level stakeholders, including district health officers, PRI members, and NGO representatives, with at least 5–6 per district engaged in workshops and consultations. 
 
ExclusionCriteria 
Details  Individuals who are unwilling or unable to participate in the study will be excluded 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
a scalable and context specific model for snakebite prevention and management, enhanced community capacity for early recognition and first aid, improved timely referral and treatment, increased awareness and adoption of safe behaviours, reduced reliance on traditional remedies, strengthened health system capacity through refresher and structured training, improved quality of clinical snakebite care, enhanced emergency response skills, efficient three-tier referral network with digital support, reduced treatment delays, and increased survival rates.  1. Preparatory-Adaptive Phase (8 months)
2. Piloting and Model Optimization Phase (11 months)
3. Implementation Phase (24 months)
 
 
Secondary Outcome  
Outcome  TimePoints 
provide evidence of pre- & post-intervention changes in awareness, attitudes, & practices across stakeholders, offering insights into behaviour change at both community & health system levels.  Pre intervention survey would be conducted at baseline. this would be during the preparatory phase-. (first 8 months of the project). Post intervention assessment will be done at the end of Intevention Phase (Full intervention phase is 24 months, the post assessment will be from 22-24 months) 
The development of a real-time snakebite surveillance dashboard will enable systematic tracking of snake rescues, sightings, killings, incidence, & mortality. This tool will provide timely data to inform prevention strategies, support resource allocation, & strengthen regional & national snakebite control policies  The dashboard will be developed during the piloting phase, 11 months after project initiation. Continuous monitoring will be undertaken to ensure data accuracy & completeness. 
 
Target Sample Size   Total Sample Size="1400"
Sample Size from India="1400" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   05/01/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="4"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Background:

Snakebite envenomation (SBE) is a neglected tropical disease responsible for an estimated 58,000 deaths annually in India, disproportionately affecting rural, tribal, and marginalized populations. Despite the availability of effective treatment with anti-snake venom (ASV), systemic gaps in awareness, timely access, and care coordination contribute to high mortality and morbidity. Fragmented local initiatives have demonstrated promise but lack scalability and integration. The Snakebite Awareness, Response, Prevention and Action (SARPA) protocol proposes an evidence-based, community-centred model to bridge these gaps through integrated prevention, preparedness, and health system strengthening.

Objectives:

To design, implement, and evaluate a scalable, adaptive, and community-driven intervention for snakebite prevention and management using the RE-AIM framework. The primary objective of the study is to co-develop, pilot and implement a replicable composite model of community engagement and empowerment for the prevention and mitigation of snakebite envenoming across diverse geographical settings of India. The secondary Objectives are : 1) To assess changes in awareness and knowledge related to snakebite envenoming (SBE) across the entire continuum of care — from community volunteers and first responders to doctors and paramedical staff managing SBE — using a pre- and post-intervention evaluation design.2) To develop and operationalise an iterative, digital snakebite dashboard for real-time documentation and monitoring of snake rescues, kills, sightings, envenoming cases, and related deaths across study sites, enabling data-driven decision-making and surveillance.

Methods:

This multicentre implementation research uses a mixed-methods approach to co-develop and evaluate a scalable, community-engaged model for snakebite prevention and health system strengthening in two blocks within seven states across the five zones of India. The study comprises three phases: a preparatory-adaptive phase (8 months), a piloting and model optimization phase (11 months), and a full implementation phase (24 months). Interventions will combine behaviour change communication, digital innovations (AI-assisted snake identification, real-time surveillance dashboards, 24×7 helpline), and structured health system capacity building. Evaluation will integrate the RE-AIM and Proctor’s frameworks to assess reach, effectiveness, adoption, implementation fidelity, and maintenance. Quantitative and qualitative analyses—including logistic regression, mixed-effects modeling, and longitudinal focus group discussions—will measure changes in awareness, preventive practices, time-to-treatment, and mortality reduction.

Expected Outcomes:

The SARPA protocol is expected to generate a replicable model for snakebite prevention and management adaptable across diverse ecological and health system contexts. By integrating community empowerment, digital technologies, and health system strengthening, the study aims to produce scalable evidence to inform India’s national snakebite strategy and contribute to the WHO’s 2030 target of halving global snakebite mortality.

 
Close